Thermogenesis Holdings Investor Relations Material
Latest events
Q3 2023
Thermogenesis Holdings
Q1 2024
17 May, 2024
Q4 2023
16 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Thermogenesis Holdings Inc
Access all reports
ThermoGenesis Holdings, Inc. previously known as Cesca Therapeutics Inc., is a developer in automated cell processing technologies for the cell and gene therapy sector. The company, through its subsidiary ThermoGenesis Corp., offers comprehensive solutions for automated clinical biobanking, point-of-care applications, and large-scale cell processing and manufacturing, particularly for the emerging CAR-T immunotherapy market. Thermogenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California, with its shares listed on the Nasdaq stock exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
THMO
Country
🇺🇸 United States